222 related articles for article (PubMed ID: 32103169)
1. Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers.
Li S; Lavrijsen M; Bakker A; Magierowski M; Magierowska K; Liu P; Wang W; Peppelenbosch MP; Smits R
Oncogene; 2020 Apr; 39(17):3458-3472. PubMed ID: 32103169
[TBL] [Abstract][Full Text] [Related]
2. The Functional Landscape of Patient-Derived RNF43 Mutations Predicts Sensitivity to Wnt Inhibition.
Yu J; Yusoff PAM; Woutersen DTJ; Goh P; Harmston N; Smits R; Epstein DM; Virshup DM; Madan B
Cancer Res; 2020 Dec; 80(24):5619-5632. PubMed ID: 33067269
[TBL] [Abstract][Full Text] [Related]
3. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
[TBL] [Abstract][Full Text] [Related]
4. The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis.
Tu J; Park S; Yu W; Zhang S; Wu L; Carmon K; Liu QJ
Sci Rep; 2019 Dec; 9(1):18557. PubMed ID: 31811196
[TBL] [Abstract][Full Text] [Related]
5. RNF43 R117fs mutant positively regulates Wnt/β-catenin signaling by failing to internalize FZD expressed on the cell surface.
Cho AR; Sul HJ; Kim YJ; Kim B; Zang DY
Sci Rep; 2022 Apr; 12(1):7013. PubMed ID: 35487932
[TBL] [Abstract][Full Text] [Related]
6. Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling.
Tsukiyama T; Fukui A; Terai S; Fujioka Y; Shinada K; Takahashi H; Yamaguchi TP; Ohba Y; Hatakeyama S
Mol Cell Biol; 2015 Jun; 35(11):2007-23. PubMed ID: 25825523
[TBL] [Abstract][Full Text] [Related]
7. RNF43 truncations trap CK1 to drive niche-independent self-renewal in cancer.
Spit M; Fenderico N; Jordens I; Radaszkiewicz T; Lindeboom RG; Bugter JM; Cristobal A; Ootes L; van Osch M; Janssen E; Boonekamp KE; Hanakova K; Potesil D; Zdrahal Z; Boj SF; Medema JP; Bryja V; Koo BK; Vermeulen M; Maurice MM
EMBO J; 2020 Sep; 39(18):e103932. PubMed ID: 32965059
[TBL] [Abstract][Full Text] [Related]
8. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
[TBL] [Abstract][Full Text] [Related]
9. Protease associated domain of RNF43 is not necessary for the suppression of Wnt/β-catenin signaling in human cells.
Radaszkiewicz T; Bryja V
Cell Commun Signal; 2020 Jun; 18(1):91. PubMed ID: 32527265
[TBL] [Abstract][Full Text] [Related]
10. eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants.
Thornton AM; Fang L; Lo A; McSharry M; Haan D; O'Brien C; Berger AH; Giannakis M; Brooks AN
PLoS Comput Biol; 2021 Jul; 17(7):e1009132. PubMed ID: 34214079
[TBL] [Abstract][Full Text] [Related]
11. Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progression.
Eto T; Miyake K; Nosho K; Ohmuraya M; Imamura Y; Arima K; Kanno S; Fu L; Kiyozumi Y; Izumi D; Sugihara H; Hiyoshi Y; Miyamoto Y; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Furukawa T; Araki K; Baba H; Ishimoto T
J Pathol; 2018 Aug; 245(4):445-455. PubMed ID: 29756208
[TBL] [Abstract][Full Text] [Related]
12. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.
Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL
Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107
[TBL] [Abstract][Full Text] [Related]
13. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ
Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495
[TBL] [Abstract][Full Text] [Related]
14. Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases.
Jiang X; Charlat O; Zamponi R; Yang Y; Cong F
Mol Cell; 2015 May; 58(3):522-33. PubMed ID: 25891077
[TBL] [Abstract][Full Text] [Related]
15. RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition.
Fang L; Ford-Roshon D; Russo M; O'Brien C; Xiong X; Gurjao C; Grandclaudon M; Raghavan S; Corsello SM; Carr SA; Udeshi ND; Berstler J; Sicinska E; Ng K; Giannakis M
Nat Commun; 2022 Jun; 13(1):3181. PubMed ID: 35676246
[TBL] [Abstract][Full Text] [Related]
16. Loss of endogenous RNF43 function enhances proliferation and tumour growth of intestinal and gastric cells.
Neumeyer V; Grandl M; Dietl A; Brutau-Abia A; Allgäuer M; Kalali B; Zhang Y; Pan KF; Steiger K; Vieth M; Anton M; Mejías-Luque R; Gerhard M
Carcinogenesis; 2019 Jun; 40(4):551-559. PubMed ID: 30380024
[TBL] [Abstract][Full Text] [Related]
17. Frequent RNF43 mutation contributes to moderate activation of Wnt signaling in colorectal signet-ring cell carcinoma.
Li Y; Li J; Wang R; Zhang L; Fu G; Wang X; Wang Y; Fang C; Zhang D; Du D; Ma X; Pan M; Guo Q; Xu X; Hu X; Zhou Y; Mo S; Wang H; Gao J; Huang S; Liu Y; Cai S; Hua G; Peng J; Yu FX
Protein Cell; 2020 Apr; 11(4):292-298. PubMed ID: 32008206
[No Abstract] [Full Text] [Related]
18. Issues with RNF43 antibodies to reliably detect intracellular location.
Li S; Zhang R; Lavrijsen M; van den Bosch TPP; Peppelenbosch MP; Smits R
PLoS One; 2023; 18(4):e0283894. PubMed ID: 37023034
[TBL] [Abstract][Full Text] [Related]
19. New insights in ubiquitin-dependent Wnt receptor regulation in tumorigenesis.
Tsukiyama T
In Vitro Cell Dev Biol Anim; 2024 May; 60(5):449-465. PubMed ID: 38383910
[TBL] [Abstract][Full Text] [Related]
20. The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear membrane.
Loregger A; Grandl M; Mejías-Luque R; Allgäuer M; Degenhart K; Haselmann V; Oikonomou C; Hatzis P; Janssen KP; Nitsche U; Gradl D; van den Broek O; Destree O; Ulm K; Neumaier M; Kalali B; Jung A; Varela I; Schmid RM; Rad R; Busch DH; Gerhard M
Sci Signal; 2015 Sep; 8(393):ra90. PubMed ID: 26350900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
